Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Japan flag Japan · Delayed Price · Currency is JPY
5,509.00
+22.00 (0.40%)
At close: Jan 23, 2026
-2.91%
Market Cap407.90B
Revenue (ttm)163.18B
Net Income (ttm)11.53B
Shares Out74.34M
EPS (ttm)155.13
PE Ratio35.37
Forward PE30.32
Dividend104.00 (1.91%)
Ex-Dividend DateDec 29, 2025
Volume173,300
Average Volume295,040
Open5,487.00
Previous Close5,487.00
Day's Range5,467.00 - 5,530.00
52-Week Range4,850.00 - 5,925.00
Beta0.28
RSI59.17
Earnings DateFeb 10, 2026

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling g... [Read more]

Founded 1886
Employees 3,615
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4967
Full Company Profile

Financial Performance

In 2024, Kobayashi Pharmaceutical's revenue was 165.60 billion, a decrease of -4.53% compared to the previous year's 173.46 billion. Earnings were 10.07 billion, a decrease of -50.50%.

Financial Statements